Tooth Discoloration and Chairside Handling Time (Bonding-Debonding) in Flowable Versus Packable Composites for Clear Aligner Bonded Attachments: A Randomized Clinical Trial

November 14, 2025 updated by: Elaf Hussein Hasan, University of Sulaimani

Comparison of Color Stability, Bonding Time, and White Spot Lesion Between Flowable Nanocomposite and Packable Microhybrid Composite Used for Clear Aligner Attachments: A Split-Mouth Randomized Clinical Trial

This randomized split-mouth clinical trial aims to compare two different composite materials used for bonding attachments in clear aligner orthodontic therapy. Twenty adult participants with Class I malocclusion and mild crowding will receive flowable nanocomposite attachments on one side of the dental arch and packable microhybrid composite attachments on the opposite side. The primary outcome is the color change (ΔE) of the enamel surface after attachment removal, measured by a spectrophotometer (VITA Easyshade). Secondary outcomes include bonding and debonding time and changes in enamel surface roughness before and after treatment. The study will be conducted at the Orthodontic Department, College of Dentistry, University of Sulaimani. The goal is to determine which composite material provides better color stability, easier handling, and minimal impact on enamel surface characteristics during clear aligner therapy.

Study Overview

Detailed Description

Clear aligner therapy has become a popular alternative to conventional fixed orthodontic appliances due to its superior esthetics and comfort. However, the efficiency of aligner treatment often depends on the proper use of composite attachments that enhance tooth movement and retention. Different composite resins are used for this purpose, but their optical stability and effect on enamel integrity after removal remain concerns.

This prospective, split-mouth randomized clinical trial compares a flowable nanocomposite and a packable microhybrid composite used for clear aligner attachments. Each participant will receive both materials in opposite quadrants to minimize inter-individual variability. Outcomes will include enamel color change (ΔE CIE Lab* values), bonding/debonding time, and surface roughness assessment using digital and optical analysis methods.

The study hypothesis is that the flowable nanocomposite will exhibit superior color stability and faster handling time, with comparable enamel surface effects to the packable composite. Results from this trial may help establish standardized protocols for attachment material selection in clinical orthodontic practice.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Kirkuk Governorate
      • Kirkuk, Kirkuk Governorate, Iraq
        • Recruiting
        • Private Orthodontic Clinic - Kirkuk
        • Contact:
    • Province
      • Kirkuk, Province, Iraq

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults 18-40 years.
  • patients with class l malocclusion with in which there treatment will be completed in 6 month .
  • Completed clear aligner therapy and scheduled for attachment debonding at the study clinic.
  • Permanent teeth with intact buccal enamel at assessment sites.
  • No caries, restorations, cracks, fluorosis, or hypoplasia on assessed surfaces.
  • No bleaching within 6 months prior to baseline.
  • Good general health (ASA I-II) and able to provide written informed consent.
  • Satisfactory oral hygiene and gingival health (e.g., GI ≤ 1).
  • Willing and able to complete measurements: spectrophotometric shade (CIE L*, a*, b*), photographs/scans, and VAS for pain/discomfort.
  • Available for all visits and follow-up assessment.

Exclusion Criteria:

  • Patients younger than 18 or older than 40 years.
  • Patients presenting with severe or very severe anterior crowding (LII > 6 mm) or spacing will exclude from the study. Cases with posterior crossbites, open bites, or skeletal discrepancies
  • Presence of systemic diseases (ASA > II) that may affect healing, pain perception, or enamel quality.
  • Teeth with caries, restorations, fractures, enamel cracks, fluorosis, hypoplasia, or discolorations on the buccal surfaces at assessment sites.
  • Patients who have undergone tooth bleaching within the last 6 months.
  • History of major dental surgery or trauma in the study region.
  • Patients with poor oral hygiene or gingival inflammation (GI > 1).
  • Pregnant or lactating women.
  • Patients with allergy or hypersensitivity to composite resins or dental adhesives.
  • Individuals unable to provide informed consent or not willing to comply with study visits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: packable microcomposite (Group A)
Participants will receive packable microcomposite attachments (e.g., GC G-ænial Universal ) on one side of the dental arc attachments on one quadrant of the dental arch for clear aligner therapy. Color change, bonding/debonding time, and enamel roughness will be assessed
Packable microhybrid composite resin used to fabricate clear aligner attachments.
Active Comparator: flowable nanohybrid Composite (Group B)
Participants will receive flowable nanocomposite (e.g., GC aligner connect ) attachments on the opposite quadrant of the same dental arch.Color change, bonding/debonding time, and enamel roughness will be assessed.
A flowable nanocomposite (e.g., GC aligne connect) used to fabricate clear aligner attachments on enamel surfaces for comparison
Other Names:
  • packable microhybrid composite

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Tooth Color (ΔE) After Attachment Removal
Time Frame: Baseline (before bonding) and after attachment removal
The color change (ΔE) of the enamel surface will be measured using a VITA Easyshade spectrophotometer based on CIE Lab* values before bonding and after debonding of the attachments. A ΔE value ≥ 3.3 will be considered clinically perceptible.
Baseline (before bonding) and after attachment removal

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali I Ibrahim, College of Dentistry, University of Sulaimani.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2025

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

December 16, 2026

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Actual)

November 18, 2025

Study Record Updates

Last Update Posted (Actual)

November 18, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • USulaimani-Ortho-Aligner-2025
  • MSc-Ortho-Aligner-Study-2025; (Other Identifier: College of Dentistry, University of Sulaimani; Research Ethics Committee, College of Dentistry, University of Sulaimani)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

ot applicable. Individual participant data will not be shared. Only summarized results will be published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clear Aligner Orthodontic Treatment

Clinical Trials on Packable Microhybrid Composite Resin

Subscribe